- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Oncology Based Preclinical CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Oncology Based Preclinical CRO market size is estimated to be worth US$ 391.3 million in 2021 and is forecast to a readjusted size of USD 857.9 million by 2028 with a CAGR of 11.9% during review period. In Vitro accounting for % of the Oncology Based Preclinical CRO global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Blood Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Oncology Based Preclinical CRO include Crown Bioscience, Charles River, ICON, Eurofins Scientific, and Taconic Biosciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology Based Preclinical CRO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Blood Cancer
Solid Tumors
Others
Market segment by Application, can be divided into
In Vitro
In Vivo
Market segment by players, this report covers
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncology Based Preclinical CRO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncology Based Preclinical CRO, with revenue, gross margin and global market share of Oncology Based Preclinical CRO from 2019 to 2022.
Chapter 3, the Oncology Based Preclinical CRO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Based Preclinical CRO market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oncology Based Preclinical CRO research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oncology Based Preclinical CRO
1.2 Classification of Oncology Based Preclinical CRO by Type
1.2.1 Overview: Global Oncology Based Preclinical CRO Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Oncology Based Preclinical CRO Revenue Market Share by Type in 2021
1.2.3 Blood Cancer
1.2.4 Solid Tumors
1.2.5 Others
1.3 Global Oncology Based Preclinical CRO Market by Application
1.3.1 Overview: Global Oncology Based Preclinical CRO Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Global Oncology Based Preclinical CRO Market Size & Forecast
1.5 Global Oncology Based Preclinical CRO Market Size and Forecast by Region
1.5.1 Global Oncology Based Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Oncology Based Preclinical CRO Market Size by Region, (2017-2022)
1.5.3 North America Oncology Based Preclinical CRO Market Size and Prospect (2017-2028)
1.5.4 Europe Oncology Based Preclinical CRO Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Oncology Based Preclinical CRO Market Size and Prospect (2017-2028)
1.5.6 South America Oncology Based Preclinical CRO Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Oncology Based Preclinical CRO Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Based Preclinical CRO Market Drivers
1.6.2 Oncology Based Preclinical CRO Market Restraints
1.6.3 Oncology Based Preclinical CRO Trends Analysis
2 Company Profiles
2.1 Crown Bioscience
2.1.1 Crown Bioscience Details
2.1.2 Crown Bioscience Major Business
2.1.3 Crown Bioscience Oncology Based Preclinical CRO Product and Solutions
2.1.4 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Crown Bioscience Recent Developments and Future Plans
2.2 Charles River
2.2.1 Charles River Details
2.2.2 Charles River Major Business
2.2.3 Charles River Oncology Based Preclinical CRO Product and Solutions
2.2.4 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Charles River Recent Developments and Future Plans
2.3 ICON
2.3.1 ICON Details
2.3.2 ICON Major Business
2.3.3 ICON Oncology Based Preclinical CRO Product and Solutions
2.3.4 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 ICON Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Oncology Based Preclinical CRO Product and Solutions
2.4.4 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 Taconic Biosciences
2.5.1 Taconic Biosciences Details
2.5.2 Taconic Biosciences Major Business
2.5.3 Taconic Biosciences Oncology Based Preclinical CRO Product and Solutions
2.5.4 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Taconic Biosciences Recent Developments and Future Plans
2.6 Covance
2.6.1 Covance Details
2.6.2 Covance Major Business
2.6.3 Covance Oncology Based Preclinical CRO Product and Solutions
2.6.4 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Covance Recent Developments and Future Plans
2.7 EVOTEC
2.7.1 EVOTEC Details
2.7.2 EVOTEC Major Business
2.7.3 EVOTEC Oncology Based Preclinical CRO Product and Solutions
2.7.4 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 EVOTEC Recent Developments and Future Plans
2.8 The Jackson Laboratory
2.8.1 The Jackson Laboratory Details
2.8.2 The Jackson Laboratory Major Business
2.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Product and Solutions
2.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 The Jackson Laboratory Recent Developments and Future Plans
2.9 MI Bioresearch
2.9.1 MI Bioresearch Details
2.9.2 MI Bioresearch Major Business
2.9.3 MI Bioresearch Oncology Based Preclinical CRO Product and Solutions
2.9.4 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 MI Bioresearch Recent Developments and Future Plans
2.10 Champion Oncology
2.10.1 Champion Oncology Details
2.10.2 Champion Oncology Major Business
2.10.3 Champion Oncology Oncology Based Preclinical CRO Product and Solutions
2.10.4 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Champion Oncology Recent Developments and Future Plans
2.11 Wuxi AppTec.
2.11.1 Wuxi AppTec. Details
2.11.2 Wuxi AppTec. Major Business
2.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Product and Solutions
2.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Wuxi AppTec. Recent Developments and Future Plans
2.12 Xentech
2.12.1 Xentech Details
2.12.2 Xentech Major Business
2.12.3 Xentech Oncology Based Preclinical CRO Product and Solutions
2.12.4 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Xentech Recent Developments and Future Plans
2.13 Living Tumor Laboratory
2.13.1 Living Tumor Laboratory Details
2.13.2 Living Tumor Laboratory Major Business
2.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Product and Solutions
2.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Living Tumor Laboratory Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Based Preclinical CRO Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Based Preclinical CRO Players Market Share in 2021
3.2.2 Top 10 Oncology Based Preclinical CRO Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Oncology Based Preclinical CRO Players Head Office, Products and Services Provided
3.4 Oncology Based Preclinical CRO Mergers & Acquisitions
3.5 Oncology Based Preclinical CRO New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Based Preclinical CRO Revenue and Market Share by Type (2017-2022)
4.2 Global Oncology Based Preclinical CRO Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Oncology Based Preclinical CRO Revenue Market Share by Application (2017-2022)
5.2 Global Oncology Based Preclinical CRO Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Based Preclinical CRO Revenue by Type (2017-2028)
6.2 North America Oncology Based Preclinical CRO Revenue by Application (2017-2028)
6.3 North America Oncology Based Preclinical CRO Market Size by Country
6.3.1 North America Oncology Based Preclinical CRO Revenue by Country (2017-2028)
6.3.2 United States Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
6.3.3 Canada Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
6.3.4 Mexico Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Based Preclinical CRO Revenue by Type (2017-2028)
7.2 Europe Oncology Based Preclinical CRO Revenue by Application (2017-2028)
7.3 Europe Oncology Based Preclinical CRO Market Size by Country
7.3.1 Europe Oncology Based Preclinical CRO Revenue by Country (2017-2028)
7.3.2 Germany Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
7.3.3 France Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
7.3.5 Russia Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
7.3.6 Italy Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Based Preclinical CRO Revenue by Type (2017-2028)
8.2 Asia-Pacific Oncology Based Preclinical CRO Revenue by Application (2017-2028)
8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region
8.3.1 Asia-Pacific Oncology Based Preclinical CRO Revenue by Region (2017-2028)
8.3.2 China Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8.3.3 Japan Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8.3.4 South Korea Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8.3.5 India Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
8.3.7 Australia Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Based Preclinical CRO Revenue by Type (2017-2028)
9.2 South America Oncology Based Preclinical CRO Revenue by Application (2017-2028)
9.3 South America Oncology Based Preclinical CRO Market Size by Country
9.3.1 South America Oncology Based Preclinical CRO Revenue by Country (2017-2028)
9.3.2 Brazil Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
9.3.3 Argentina Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Based Preclinical CRO Revenue by Type (2017-2028)
10.2 Middle East & Africa Oncology Based Preclinical CRO Revenue by Application (2017-2028)
10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country
10.3.1 Middle East & Africa Oncology Based Preclinical CRO Revenue by Country (2017-2028)
10.3.2 Turkey Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
10.3.4 UAE Oncology Based Preclinical CRO Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Oncology Based Preclinical CRO Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Oncology Based Preclinical CRO Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Oncology Based Preclinical CRO Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Oncology Based Preclinical CRO Revenue (USD Million) by Region (2017-2022)
Table 5. Global Oncology Based Preclinical CRO Revenue Market Share by Region (2023-2028)
Table 6. Crown Bioscience Corporate Information, Head Office, and Major Competitors
Table 7. Crown Bioscience Major Business
Table 8. Crown Bioscience Oncology Based Preclinical CRO Product and Solutions
Table 9. Crown Bioscience Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Charles River Corporate Information, Head Office, and Major Competitors
Table 11. Charles River Major Business
Table 12. Charles River Oncology Based Preclinical CRO Product and Solutions
Table 13. Charles River Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. ICON Corporate Information, Head Office, and Major Competitors
Table 15. ICON Major Business
Table 16. ICON Oncology Based Preclinical CRO Product and Solutions
Table 17. ICON Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Eurofins Scientific Major Business
Table 20. Eurofins Scientific Oncology Based Preclinical CRO Product and Solutions
Table 21. Eurofins Scientific Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Taconic Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Taconic Biosciences Major Business
Table 24. Taconic Biosciences Oncology Based Preclinical CRO Product and Solutions
Table 25. Taconic Biosciences Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Covance Corporate Information, Head Office, and Major Competitors
Table 27. Covance Major Business
Table 28. Covance Oncology Based Preclinical CRO Product and Solutions
Table 29. Covance Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. EVOTEC Corporate Information, Head Office, and Major Competitors
Table 31. EVOTEC Major Business
Table 32. EVOTEC Oncology Based Preclinical CRO Product and Solutions
Table 33. EVOTEC Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. The Jackson Laboratory Corporate Information, Head Office, and Major Competitors
Table 35. The Jackson Laboratory Major Business
Table 36. The Jackson Laboratory Oncology Based Preclinical CRO Product and Solutions
Table 37. The Jackson Laboratory Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. MI Bioresearch Corporate Information, Head Office, and Major Competitors
Table 39. MI Bioresearch Major Business
Table 40. MI Bioresearch Oncology Based Preclinical CRO Product and Solutions
Table 41. MI Bioresearch Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Champion Oncology Corporate Information, Head Office, and Major Competitors
Table 43. Champion Oncology Major Business
Table 44. Champion Oncology Oncology Based Preclinical CRO Product and Solutions
Table 45. Champion Oncology Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Wuxi AppTec. Corporate Information, Head Office, and Major Competitors
Table 47. Wuxi AppTec. Major Business
Table 48. Wuxi AppTec. Oncology Based Preclinical CRO Product and Solutions
Table 49. Wuxi AppTec. Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Xentech Corporate Information, Head Office, and Major Competitors
Table 51. Xentech Major Business
Table 52. Xentech Oncology Based Preclinical CRO Product and Solutions
Table 53. Xentech Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Living Tumor Laboratory Corporate Information, Head Office, and Major Competitors
Table 55. Living Tumor Laboratory Major Business
Table 56. Living Tumor Laboratory Oncology Based Preclinical CRO Product and Solutions
Table 57. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Oncology Based Preclinical CRO Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Oncology Based Preclinical CRO Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Oncology Based Preclinical CRO Players Head Office, Products and Services Provided
Table 62. Oncology Based Preclinical CRO Mergers & Acquisitions in the Past Five Years
Table 63. Oncology Based Preclinical CRO New Entrants and Expansion Plans
Table 64. Global Oncology Based Preclinical CRO Revenue (USD Million) by Type (2017-2022)
Table 65. Global Oncology Based Preclinical CRO Revenue Share by Type (2017-2022)
Table 66. Global Oncology Based Preclinical CRO Revenue Forecast by Type (2023-2028)
Table 67. Global Oncology Based Preclinical CRO Revenue by Application (2017-2022)
Table 68. Global Oncology Based Preclinical CRO Revenue Forecast by Application (2023-2028)
Table 69. North America Oncology Based Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Oncology Based Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Oncology Based Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Oncology Based Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Oncology Based Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Oncology Based Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Oncology Based Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Oncology Based Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Oncology Based Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Oncology Based Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Oncology Based Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Oncology Based Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Oncology Based Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Oncology Based Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Oncology Based Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Oncology Based Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Oncology Based Preclinical CRO Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Oncology Based Preclinical CRO Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Oncology Based Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Oncology Based Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Oncology Based Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Oncology Based Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Oncology Based Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Oncology Based Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Oncology Based Preclinical CRO Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Oncology Based Preclinical CRO Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Oncology Based Preclinical CRO Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Oncology Based Preclinical CRO Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Oncology Based Preclinical CRO Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Oncology Based Preclinical CRO Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Oncology Based Preclinical CRO Picture
Figure 2. Global Oncology Based Preclinical CRO Revenue Market Share by Type in 2021
Figure 3. Blood Cancer
Figure 4. Solid Tumors
Figure 5. Others
Figure 6. Oncology Based Preclinical CRO Revenue Market Share by Application in 2021
Figure 7. In Vitro Picture
Figure 8. In Vivo Picture
Figure 9. Global Oncology Based Preclinical CRO Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Oncology Based Preclinical CRO Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Oncology Based Preclinical CRO Revenue Market Share by Region (2017-2028)
Figure 12. Global Oncology Based Preclinical CRO Revenue Market Share by Region in 2021
Figure 13. North America Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Oncology Based Preclinical CRO Market Drivers
Figure 19. Oncology Based Preclinical CRO Market Restraints
Figure 20. Oncology Based Preclinical CRO Market Trends
Figure 21. Crown Bioscience Recent Developments and Future Plans
Figure 22. Charles River Recent Developments and Future Plans
Figure 23. ICON Recent Developments and Future Plans
Figure 24. Eurofins Scientific Recent Developments and Future Plans
Figure 25. Taconic Biosciences Recent Developments and Future Plans
Figure 26. Covance Recent Developments and Future Plans
Figure 27. EVOTEC Recent Developments and Future Plans
Figure 28. The Jackson Laboratory Recent Developments and Future Plans
Figure 29. MI Bioresearch Recent Developments and Future Plans
Figure 30. Champion Oncology Recent Developments and Future Plans
Figure 31. Wuxi AppTec. Recent Developments and Future Plans
Figure 32. Xentech Recent Developments and Future Plans
Figure 33. Living Tumor Laboratory Recent Developments and Future Plans
Figure 34. Global Oncology Based Preclinical CRO Revenue Share by Players in 2021
Figure 35. Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Oncology Based Preclinical CRO Revenue Market Share in 2021
Figure 37. Global Top 10 Players Oncology Based Preclinical CRO Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Oncology Based Preclinical CRO Revenue Share by Type in 2021
Figure 40. Global Oncology Based Preclinical CRO Market Share Forecast by Type (2023-2028)
Figure 41. Global Oncology Based Preclinical CRO Revenue Share by Application in 2021
Figure 42. Global Oncology Based Preclinical CRO Market Share Forecast by Application (2023-2028)
Figure 43. North America Oncology Based Preclinical CRO Sales Market Share by Type (2017-2028)
Figure 44. North America Oncology Based Preclinical CRO Sales Market Share by Application (2017-2028)
Figure 45. North America Oncology Based Preclinical CRO Revenue Market Share by Country (2017-2028)
Figure 46. United States Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Oncology Based Preclinical CRO Sales Market Share by Type (2017-2028)
Figure 50. Europe Oncology Based Preclinical CRO Sales Market Share by Application (2017-2028)
Figure 51. Europe Oncology Based Preclinical CRO Revenue Market Share by Country (2017-2028)
Figure 52. Germany Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Oncology Based Preclinical CRO Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Oncology Based Preclinical CRO Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Region (2017-2028)
Figure 60. China Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Oncology Based Preclinical CRO Sales Market Share by Type (2017-2028)
Figure 67. South America Oncology Based Preclinical CRO Sales Market Share by Application (2017-2028)
Figure 68. South America Oncology Based Preclinical CRO Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Oncology Based Preclinical CRO Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Oncology Based Preclinical CRO Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Oncology Based Preclinical CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
